| Univariable analysis | Stepwise multivariable analysis | ||
---|---|---|---|---|
Variable | HR (95% CI) | P value | HR (95% CI) | P value |
Male gender | 1.24 (0.42–3.60) | 0.70 | not included | - |
Hyperlipidemia | 0.81 (0.29–2.27) | 0.69 | not included | - |
Serum creatinine, μmol/l | 1.01 (0.98–1.03) | 0.64 | not included | - |
CK-MBmax, μmol/l | 1.04 (0.99–1.08) | 0.08 | - | - |
TIMI-risk score | 1.31 (1.07–1.60) | 0.009 | - | - |
ST-segment resolution, % | 0.99 (0.98–1.01) | 0.07 | not included | - |
TIMI-flow pre-PCI 0 | 1.20 (0.83–1.75) | 0.32 | not included | - |
TIMI-flow post-PCI 0-II | 4.39 (1.73–11.15) | 0.002 | - | - |
LV-EFecho, % | 0.94 (0.89–0.98) | 0.005 | - | - |
Time-to-revascularization, min | 1.00 (0.99–1.01) | 0.25 | not included | - |
LV-EFCMR, % | 0.95 (0.92–0.98) | 0.003 | - | - |
Infarct size, %LV | 1.07 (1.04–1.10) | <0.001 | - | - |
MO, %LV | 1.09 (1.02–1.21) | 0.01 | - | - |
MSI | 0.93 (0.92–0.95) | <0.001 | 0.93 (0.90–0.95) | <0.001 |